Ser87
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser87  -  Snail2 (human)

Site Information
SSSLGRVsPPPPsDT   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 25525400

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mass spectrometry ( 1 , 2 ) , mutation of modification site ( 1 , 3 ) , phospho-antibody ( 1 ) , western blotting ( 1 , 3 )
Disease tissue studied:
breast cancer ( 1 , 3 ) , melanoma skin cancer ( 2 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
ERK2 (human) ( 1 )
Kinases, in vitro:
ERK2 (human) ( 1 )
Treatments:
selumetinib ( 2 ) , U0126 ( 1 ) , vemurafenib ( 2 )

Downstream Regulation
Effects of modification on biological processes:
cell motility, induced ( 1 ) , transcription, induced ( 1 )

References 

1

Virtakoivu R, et al. (2015) Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function. Cancer Res 75, 2349-62
25855378   Curated Info

2

Stuart SA, et al. (2015) A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells. Mol Cell Proteomics 14, 1599-615
25850435   Curated Info

3

Kim JY, et al. (2012) Functional regulation of Slug / Snail2 is dependent on GSK-3β-mediated phosphorylation. FEBS J 279, 2929-39
22727060   Curated Info